Fingerprint
Dive into the research topics of 'Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: Study protocol for a randomized controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: Study protocol for a randomized controlled trial
Bjørn Stæhr Madsen*, Jonel Trebicka, Maja Thiele, Mads Israelsen, Manimozhiyan Arumugan, Troels Havelund, Aleksander Krag
*Corresponding author for this work
Research output: Contribution to journal › Journal article › Research › peer-review
259
Downloads
(Pure)